|
AU2019205861A1
|
|
Methods for treating colorectal and metastatic colorectal cancers
|
|
SG11201907442UA
|
|
METHODS FOR INCREASING BLOOD PLASMA 2'-DEOXYURIDINE (dUrd) AND THYMIDYLATE SYNTHASE INHIBITION
|
|
WO2018065446A1
|
|
[6r]-mthf - an efficient folate alternative in 5-fluorouracil based chemotherapy
|
|
WO2018065445A1
|
|
[6r]-mthf multiple bolus administration in 5-fluorouracil based chemotherapy
|
|
EP3446703A1
|
|
6r]-mthf multiple bolus administration in 5-fluorouracil based chemotherapy
|
|
EP3446704A1
|
|
[6r]-mthf - an efficient folate alternative in 5-fluorouracil based chemotherapy
|
|
EP3305318A1
|
|
[6r]-5,10-methylenetetrahydrofolate in 5-fluorouracil based chemotherapy
|
|
HK1203152A1
|
|
Tetrahydrofolates in combination with egfr-inhibitors / egfr
|
|
WO2015114099A1
|
|
Administration regime
|
|
EP2617422A1
|
|
Anti-tumor activity of reduced folates like methylene-tetrahydrofolate, tetrahydrofolate or methyl-tetrahydrofolate
|
|
EP2617421A1
|
|
Tetrahydrofolates in combination with EGFR-inhibitors in the use of treating cancer
|
|
EP1699462A1
|
|
Combination of [6R]-methylenetetrahydrofolate with multi-targeting antifolates to reduce their toxicity while treating cancer
|
